Vincent Rajkumar: Daratumumab Is Approved in Europe for High-Risk Smoldering Myeloma
10 Must-Read Posts in GI Oncology This Week
Julie Torode: Changing the Narrative to Investing in Our Communities’ Health at AORTIC 2025
Alba Fiorentino: Conventional vs Hypofractionated Chemoradiotherapy in Glioblastoma Patients
100 Influential People in Oncology 2025 - Nominations are Open!
Evolution Trial Evaluates Radiotherapy-Free Chemoimmunotherapy with Pembrolizumab in Locally Advanced NSCLC with High PD-L1 Expression
Dr. Emrullah Yilmaz Joins Johnson and Johnson as Senior Medical Director
Razelle Kurzrock: Pancreatic Cancers with KRA G12R Can Respond to MeK Inhibitors
